FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Do More to Promote Generic Competition: White Paper

A Brookings Institution white paper lists six policy changes FDA could make to enhance generic drug competition.

latest-news-card-1

Califf on Tweaking Accelerated Approvals, No Big Revamp

FDA commissioner Robert Califf says a total revamp of the drug accelerated approval program is not needed to answer criticism following a number of dr...

Human Drugs

Whole-of-Governments Approach to Illicit Medical Products

FDA says it is working with the Organization of Economic Cooperation and Development on a whole-of-governments approach to fighting illicit medical pr...

Medical Devices

FDA to Study Breast Implant Risk Perception

FDA says it is funding a study of patient perceptions of the risk of a specific cancer associated with textured breast implants.

Biologics

Panel Backs Moderna Covid Vaccine in Children

An FDA advisory committee votes unanimously (22 to 0) to recommend the agency grant Moderna an emergency use authorization for its Covid-19 vaccine in...

Human Drugs

ICH Draft Quality Risk Management Guidance

FDA publishes a draft International Council for Harmonization guidance on quality risk management with no new regulatory expectations.

Federal Register

Notice Corrected on Donor Eligibility Requirements

Federal Register notice: FDA corrects a 5/24 notice on a draft guidance being made available entitled "Blood Pressure and Pulse Donor Eligibility Requ...

Biologics

Pfizer, Moderna Vaccines Safe & Effective in Children: FDA

As FDA prepares for a 6/14-15 advisory committee meeting on pediatric Covid-19 vaccines, agency briefing documents find the Pfizer-BioNTech and Modern...

Federal Register

Comments Extended on Antimicrobial Drug Use

Federal Register notice: FDA extends the comment period for a 2/16 notice that requested comments on antimicrobial drug use practices in companion ani...

Human Drugs

FDA OKs Cancer Drugs Faster/Sooner Than EMA: Study

A new JAMA online study finds that FDA reviews and approves new oncology therapies much faster and sooner than the EMA.